Patent details
300821
Product Name:
TALIMOGENE LAHERPAREPVEC
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300821
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1252323
Status:
Withdrawn
Application number:
300821
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/15/1064
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/12/2015
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
14/06/2016
First Marketing Authorization date:
18/12/2015
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
21/06/2016
SPC/SPC Extension Expiration Date:
21/01/2026
Lapsed By Expiration Date:
Withdrawal date:
21/10/2016
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
21/06/2016
Name:
BioVex Limited
Address:
70 Milton Park, OX14 4RX, Abingdon, Oxford, United Kingdom (GB)
Agent
Name:
J.M.H. Duyver lic.
From:
21/06/2016
Address:
Gevers Patents
Holidaystraat 5, B-1831, Diegem, Belgium (BE)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
47/16
Publication date:
23/11/2016
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
43/16
Publication date:
28/10/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
25/16
Publication date:
22/06/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/01/2021
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
17/11/2016
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/1/0/5/6/0800065013/docs/300821_6_outgoingcorrespondence20161118093443799.pdf
21/10/2016
Incoming Correspondence Paper
Response applicant or agent
1
PDF
/3/1/0/5/6/0800065013/docs/300821_3_incomingcorrespondencepaper20161025054840988.pdf
21/10/2016
SPC Documents
Power of Attorney SPC
1
PDF
/3/1/0/5/6/0800065013/docs/300821_10_supplprotectioncertificate20161025054841080.pdf
20/10/2016
Incoming Correspondence Paper
Fax
3
PDF
/3/1/0/5/6/0800065013/docs/300821_13_incomingcorrespondencepaper20161020024536762.pdf
21/07/2016
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/1/0/5/6/0800065013/docs/300821_0_outgoingcorrespondence20160722104818090.pdf
21/07/2016
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/1/0/5/6/0800065013/docs/300821_1_71132l173.pdf
22/06/2016
Outgoing Correspondence
Outgoing Letter
1
PDF
/3/1/0/5/6/0800065013/docs/300821_4_63973l174.pdf
16/06/2016
SPC Documents
Marketing Authorization SPC
5
PDF
/3/1/0/5/6/0800065013/docs/300821_2_supplprotectioncertificate20160620035330760.pdf
16/06/2016
Application Form
First filed application form
3
PDF
/3/1/0/5/6/0800065013/docs/300821_5_applicationform20160620035330411.pdf
16/06/2016
SPC Documents
Marketing Authorization SPC
4
PDF
/3/1/0/5/6/0800065013/docs/300821_8_supplprotectioncertificate20160620035330848.pdf
16/06/2016
SPC Documents
Marketing Authorization SPC
41
PDF
/3/1/0/5/6/0800065013/docs/300821_9_supplprotectioncertificate20160620035330930.pdf
16/06/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/3/1/0/5/6/0800065013/docs/300821_11_incomingcorrespondencepaper20160620035330667.pdf
16/06/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/3/1/0/5/6/0800065013/docs/300821_12_incomingcorrespondencepaper20160620035330586.pdf
14/06/2016
Incoming Correspondence Paper
Fax
62
PDF
/3/1/0/5/6/0800065013/docs/300821_7_incomingcorrespondencepaper20160621011211898.pdf